Collexis Selected as Knowledge Platform for the National Institutes of Health

Collexis Selected as Knowledge Platform for the National Institutes of Health

July 11, 2007

Significant Client Development for Knowledge Discovery
Company

    COLUMBIA, S.C., July 11 /Xinhua-PRNewswire/ --
Following the announcement of the company's public listing,
Collexis (OTC Bulletin Board: CLXS) has signed an Enterprise
License Agreement and ongoing engagement with the National
Institutes of Health (NIH), replacing the Company's prior
license with NIH.  The National Institutes of Health is the
largest funder of health sciences research in the world. 
Over $20B a year in federal grant funding will now be
analyzed by the Collexis platform.  The agreement also
enables all the NIH Institutes to utilize the company's
software for categorization, search, expertise
identification, discovery and analysis of text-based
content.  Content examples include publications, grants,
patents and other scientific works and information.

    "We are very excited about our relationship with
the NIH and are confident Collexis will be a valuable asset
to its 27 institutions.  The Collexis analysis of grant
content fits with the NIH's Roadmap toward a digital future
in research.  Our software will help increase efficiency,
consistency and transparency as it pertains to the
Institutes' needs," said Bill Kirkland, CEO, Collexis
Holdings, Inc.

    This arrangement represents an important milestone for
Collexis and adds another elite, first-mover institution to
the ranks of those who have adopted Collexis' research
software, including Johns Hopkins University, Harvard
University, Morehouse School of Medicine, University of
California, San Francisco, University of South Carolina,
Bristol-Myers Squibb, Merck & Co. Inc., Lockheed
Martin, the World Health Organization, Wellcome Trust, and
others.  "With the addition of NIH and Wellcome Trust,
Collexis has now become the grants categorization,
management and reporting standard for the largest public
and largest private health science research funders in the
world," stated Steve Leicht, Collexis VP of Sales. 
"The NIH has their pick of the best technology.  We
are gratified that NIH has used its expertise, time and
talent to do the necessary examination and comparison and
has selected Collexis as its provider of text analysis
software. Clearly, Collexis is at the leading edge of the
marketplace," Leicht added.

    The Collexis application suite fingerprints private and
public health sciences databases including PubMed,
Grants.gov, Clinical Trials data, Web Data and other
sources/publications, as well as internal corporate and
enterprise content for analysis.

    Collexis Holdings, Inc.

    Collexis Holdings, Inc., a global knowledge discovery
company since 1999, is headquartered in Columbia, South
Carolina (USA) with two subsidiaries; Collexis Inc. in
Columbia, South Carolina, USA and Collexis, B.V. in
Geldermalsen, The Netherlands.  Collexis' patented
technology builds conceptual profiles of text, called
Fingerprints, from documents, websites, e-mails and other
digitized content to create applications.  The results are
often described as "finding needles in many
haystacks."  Through this novel approach, Collexis can
build unique applications to search, index, and aggregate
information as well as prioritize, trend and predict data
based on sources in multiple fields, without the
limitations of language or dialect.  The company's mission
is to develop software supporting knowledge retrieval and
discovery across multiple industries.  For more information
visit http://www.collexis.com . 

    This press release contains forward-looking statements.
Such statements are valid only as of today, and we disclaim
any obligation to update this information.  These
statements are subject to known and unknown risks and
uncertainties that may cause actual future experience and
results to differ materially from the statements made. 
These statements are based on our current beliefs and
expectations as to future outcomes.  Factors that could
affect future performance include business and economic
trends, the ability to continue funding operating losses,
fluctuations in operating results, continued success in
developing our research software and other risk factors as
disclosed in our public filings with the Securities and
Exchange Commission.

    National Institutes of Health (NIH) is not considered a
supporter or partner of Collexis.  Reference to NIH in the
above shall not be construed as a Government endorsement
nor does it obligate NIH to a position on or about the
Collexis Software.



    For more information, please contact:

     Darrell W. Gunter
     Collexis Holdings, Inc.
     Tel:   [phone]
     Email: [e-mail]